Global In Vitro Diagnostics (IVD) Market to Generate USD 118.57 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting

Increase in demand for diagnostic devices with surge in incidences of infectious and chronic diseases such as diabetes, tuberculosis (TB), cardiovascular diseases, and cancer propels the in vitro diagnostics market growth worldwide.

Newton, Connecticut, UNITED STATES

New York, Aug. 19, 2022 (GLOBE NEWSWIRE) -- According to the report published by Next Move Strategy Consulting, the global in vitro diagnostics (IVD) market generated USD 86.51 billion in 2021, and is expected to generate USD 118.57 billion by 2030, registering a CAGR of 3.3% from 2022 to 2030. The research provides an extensive analysis of changing trends of the market based on driving factors and opportunities. Moreover, the report highlights the competitive scenario.

Leading players, investors, and startups can avail insights to take necessary steps with highest-revenue generating and fastest-growing segments mentioned in the research. With nearly 700 pages containing information, data, and statistics presented in nearly 400 tables and 369 figures, the report becomes a thorough source of insights on the in vitro diagnostics industry.

Request a free sample:

Report Coverage Details
Forecast Period 2022–2030
Base Year 2021
Market Size in 2021 USD 86.51 Billion
Market Size in 2030 USD 118.57 Billion
CAGR 3.3%
No. of Pages 690
Tables 399
Figures 369
Segments covered Product & Service, Technique, Application, End User, and Geography.
Drivers Increase in demand for diagnostic devices
Surge in incidences of infectious and chronic diseases
Opportunities Integration of artificial intelligence (AI) and internet of things (IoT) in IVD equipment

The report outlines the changing trends of the global IVD market based on driving factors, restrains, and opportunities. Increase in demand for diagnostic devices with surge in incidences of infectious and chronic diseases such as diabetes, tuberculosis (TB), cardiovascular diseases, and cancer propels the growth of the in vitro diagnostics market worldwide. However, the requirement of high investment and maintenance costs for IVD equipment and shortage of reagents restrain the market growth.

Highlighting the opportunities that would enable the increase in the in vitro diagnostics market size in the next few years, the Lead Analyst for the Life Sciences & Healthcare at Next Move Strategy Consulting, stated, “Integration of artificial intelligence (AI) and internet of things (IoT) in IVD equipment will create new opportunities in the coming years. These technologies will assist in remote monitoring and management of patients, which, in turn, lead to growth of the IVD industry.”

Buy this report directly from here:

The report offers a detailed segmentation of the global in vitro diagnostics market based on product & service, technique, application, end user, and geography. Based on product & service, the report sub-segments the market into reagents, instruments, and software & services. By technique, the report sub-classifies the market into immunodiagnostics, molecular diagnostics, hematology, tissue diagnostics, clinical chemistry, and others. The immunodiagnostics segment is sub-divided into radioimmunoassay (RIA), enzyme-linked immunosorbent assay (ELISA), enzyme-linked immunospot (ELISPOT), rapid tests, and western blot. The molecular diagnostics segment is further classified into polymerize chain reaction (PCR), hybridization, isothermal nucleic acid amplification technology (INAAT), microarray, DNA diagnostics, and others. The clinical chemistry segment is further segmented into basic metabolic panel, renal profile, liver panel, thyroid function panel, lipid profile, electrolyte panel, and specialty chemicals.

Based on application, the research sub-divides the in vitro diagnostics (IVD) market into infectious diseases, immune system disorders, cancer, nephrological diseases, cardiac diseases, gastrointestinal diseases, and others. By end user, the report sub-segments the market into point of care, academic & medical schools, hospitals, standalone laboratory, and others.

Need a customized report, get in touch with us here:

On the basis of geography, the report sub-divides the global in vitro diagnostics (IVD) market into North America, Europe, Asia-Pacific, and RoW. North America held the highest market share in 2021, and is estimated to dominate throughout the forecast period. This is due to well-established healthcare infrastructure and adoption of advanced IVD equipment by healthcare providers in the private sector. However, Asia-Pacific will grow steadily over the forecast period, owing to surge in adoption of point-of-care diagnostics (POCD) and increase in IVD tests in countries such as China and India.

The report offers a comprehensive analysis of each region and respective countries based on segments and sub-segments. This analysis is helpful in gaining a strong position and raising the in vitro diagnostics market share.

If you have any queries, you can enquire before purchasing:

The report provides extensive analysis of leading market players of the global in vitro diagnostics market. These market players include Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioMerieux SA, Sysmex Corporation, F. Hoffmann-La Roche AG, Danaher Corporation (Beckman Coulter, Inc.), QIAGEN N.V., Siemens AG, and Thermo Fisher Scientific, Inc. The report also highlights the strategic moves and developments of these players to highlight the competitive scenario.

Buy a full report here:

Also, Browse Related Reports:

Immunodiagnostics Market by Product (Instruments, Reagents & Consumables and Software and Services), by Technology (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Radioimmunoassay, Fluorescence Immunoassay, Rapid Tests and Others), By Application (Infectious Diseases, Oncology and Endocrinology, Bone and Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring and Other Applications), By End-user (Hospitals, Clinical Laboratories, Academic and Research Cent, and Others)- Global Opportunity Analysis and Industry Forecasts, 2021–2030  

Brain Tumor Diagnosis & Therapeutics Market by Product (MRI, CT Scan, Tissue Sampling, PET-CT Scan, Cerebral Arteriogram, Lumbar Puncture, Molecular Testing, EEG) by Therapeutics (Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Targeted Therapy) Global Opportunity Analysis and Industry Forecast, 2020–2030

Allergy Diagnostics and Therapeutics Market by Product (Instruments, Consumables, Services), By Allergen Type (Food, Inhaled, Drug), By End-user (Research Institutes, Hospitals, Diagnostic Laboratories), By Test (In Vivo, In Vitro), By Drug Class (Antihistamines, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Decongestants, Immunomodulators, Auto injectable Epinephrine, Immunotherapy) Global Opportunity Analysis and Industry Forecast, 2020–2030

About Us:

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analyzed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top quality research and the obsession of turning data into knowledge by dissecting every bits of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enable them to move beyond time and have competitive edge in the industry.

We have been servicing over 1,000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.


Contact Data